Researchers published results supporting continuous fetal monitoring using a wearable ultrasound patch designed to reduce dependence on highly trained sonographers. The work—led by a team associated with UC San Diego and published in Nature Biotechnology—presents the device as an alternative to intermittent ultrasound assessments, particularly for high-risk pregnancies. Separate reporting describes the same UPatch concept as “autonomous” fetal monitoring, with an emphasis on continuous data capture and risk-focused evaluation rather than single snapshots. The development targets a long-standing clinical gap: access limitations to frequent, skilled ultrasound scans for expectant patients. For biotech and medtech stakeholders, the update highlights an emerging convergence—wearable sensing, signal processing, and clinical validation—where differentiation depends on study endpoints, safety, and performance across gestational ages and patient populations.